News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,151 Results
Type
Article (87243)
Company Profile (722)
Press Release (770159)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232978)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91206)
Employer Resources (201)
FDA (18247)
Job Trends (17387)
News (397207)
Policy (39898)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (34)
Allergies (119)
Alliances (56979)
ALS (136)
Alzheimer's disease (1645)
Antibody-drug conjugate (ADC) (206)
Approvals (18240)
Artificial intelligence (455)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (436)
Cancer (3536)
Cardiovascular disease (308)
Career advice (3551)
Career pathing (36)
CAR-T (230)
CDC (48)
Cell therapy (628)
Cervical cancer (29)
Clinical research (74938)
Collaboration (1284)
Company closure (4)
Compensation (861)
Complete response letters (50)
COVID-19 (2941)
CRISPR (77)
C-suite (509)
Cystic fibrosis (130)
Data (3779)
Decentralized trials (2)
Denatured (58)
Depression (98)
Diabetes (421)
Diagnostics (7045)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (215)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98641)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132421)
Executive appointments (956)
FDA (20480)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1136)
Gene editing (164)
Generative AI (45)
Gene therapy (497)
GLP-1 (994)
Government (5348)
Grass and pollen (7)
Guidances (333)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (223)
Immuno-oncology (18)
Indications (46)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (162)
Interviews (815)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (31)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (23)
Management (65)
Manufacturing (568)
MASH (117)
Medical device (14829)
Medtech (14847)
Mergers & acquisitions (22675)
Metabolic disorders (1072)
Multiple sclerosis (117)
NASH (23)
Neurodegenerative disease (183)
Neuropsychiatric disorders (50)
Neuroscience (2539)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (537)
Opinion (304)
Ovarian cancer (114)
Pain (153)
Pancreatic cancer (146)
Parkinson's disease (214)
Partnered (27)
Patents (383)
Patient recruitment (271)
Peanut (57)
People (66065)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23103)
Phase II (32545)
Phase III (24488)
Pipeline (2453)
Policy (279)
Postmarket research (3554)
Preclinical (10433)
Press Release (72)
Prostate cancer (173)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (599)
Real estate (7411)
Recruiting (76)
Regulatory (27691)
Reports (64)
Research institute (2676)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (188)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (94)
Tariffs (82)
The Weekly (103)
Vaccines (1010)
Venture capital (63)
Weight loss (372)
Women's health (56)
Worklife (21)
Date
Today (169)
Last 7 days (498)
Last 30 days (2479)
Last 365 days (33927)
2025 (23690)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (295)
Arkansas (14)
Asia (50801)
Australia (8923)
California (8915)
Canada (2702)
China (840)
Colorado (377)
Connecticut (395)
Delaware (240)
Europe (116667)
Florida (1314)
Georgia (303)
Hawaii (3)
Idaho (67)
Illinois (787)
India (45)
Indiana (430)
Iowa (19)
Japan (269)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1217)
Massachusetts (6714)
Michigan (295)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2457)
New Mexico (31)
New York (2426)
North Carolina (1361)
North Dakota (10)
Northern California (3958)
Ohio (281)
Oklahoma (18)
Oregon (49)
Pennsylvania (1856)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3396)
Tennessee (142)
Texas (1392)
United States (33065)
Utah (266)
Virginia (239)
Washington D.C. (82)
Washington State (765)
West Virginia (4)
Wisconsin (91)
There are 858,151 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025
September 17, 2025
·
8 min read
Press Releases
AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone and Royalty-Free Access to AbTherx’s Premier Human Antibody Discovery Technology
September 17, 2025
·
4 min read
Startups
Ollin Emerges From Stealth with $100M To Develop Eye Disease Bispecifics
OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster treatment for wet macular degeneration and diabetic macular edema.
September 17, 2025
·
2 min read
·
Tristan Manalac
Career Advice
Stop Selling the Dream, Start Telling the Truth
Transparency doesn’t drive people away. It attracts the right ones and keeps them committed. Leadership coach Angela Justice discusses the problem with leaders only selling the upside and the value of setting accurate expectations from the start.
September 17, 2025
·
3 min read
·
Angela Justice
Press Releases
Oruka Therapeutics Announces $180 Million Private Placement
September 17, 2025
·
6 min read
Press Releases
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001
September 17, 2025
·
9 min read
Press Releases
Navigator Medicines Announces Positive Phase 1a Data from its Program of Potential Best-in-Class Bispecific Antibodies; NAV-240 Poised for Further Development in Inflammatory Disorders and Autoimmune Diseases
September 17, 2025
·
3 min read
Press Releases
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
September 17, 2025
·
8 min read
Press Releases
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
September 17, 2025
·
3 min read
Press Releases
Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease
September 17, 2025
·
2 min read
1 of 85,816
Next
